MYMX — Mymetics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $85.29m
- €1.03m
Annual cashflow statement for Mymetics, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.17 | -4.19 | -4.16 | -4.73 | -4.8 |
| Depreciation | |||||
| Non-Cash Items | 0.013 | 0.002 | 0 | — | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.82 | 3.19 | 2.44 | 3.01 | 3.1 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -2.31 | -0.972 | -1.7 | -1.7 | -1.69 |
| Capital Expenditures | 0 | -0.036 | -0.014 | -0.01 | -0.002 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | 0 | -0.036 | -0.014 | -0.01 | -0.002 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.6 | 1.2 | 2.11 | 1.2 | 1.44 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.701 | 0.204 | 0.4 | -0.512 | -0.258 |